Ken Griffin Verastem, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.39 - $0.71 $74,133 - $134,961	-190,087 Reduced 84.37%	35,222 $14,000
Q4 2022 Feb 14, 2023	SELL	$0.33 - $10.44 $43,302 - $1.37 Million	-131,219 Reduced 36.8%	225,309 $90,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $261,989 - $3.18 Million	284,771 Added 396.85%	356,528 $303,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $76,987 - $138,124	-75,478 Reduced 51.26%	71,757 $84,000
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $181,289 - $359,158	-171,028 Reduced 53.74%	147,235 $208,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $472,541 - $737,625	230,508 Added 262.67%	318,263 $652,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $561,390 - $899,551	-221,020 Reduced 71.58%	87,755 $270,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $142,909 - $269,693	55,607 Added 21.96%	308,775 $1.26 Million
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $131,331 - $194,924	69,122 Added 37.56%	253,168 $625,000
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $26,606 - $55,526	23,136 Added 14.38%	184,046 $392,000
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $164,066 - $248,317	147,808 Added 1128.13%	160,910 $195,000
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $893,509 - $2.22 Million	-528,704 Reduced 97.58%	13,102 $23,000
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $536,302 - $1.44 Million	425,637 Added 366.39%	541,806 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $2,677 - $4,482	3,113 Added 2.75%	116,169 $156,000
Q3 2019 Nov 14, 2019	BUY	$1.21 - $1.59 $23,532 - $30,922	19,448 Added 20.78%	113,056 $136,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $966,736 - $2.43 Million	-773,389 Reduced 89.2%	93,608 $142,000
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $1.32 Million - $1.93 Million	472,049 Added 119.52%	866,997 $0
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $5,316 - $11,538	-1,646 Reduced 0.42%	394,948 $1.33 Million
Q3 2018 Nov 13, 2018	BUY	$6.86 - $9.97 $1.56 Million - $2.27 Million	227,246 Added 134.19%	396,594 $0
Q2 2018 Aug 10, 2018	BUY	$2.88 - $8.67 $435,841 - $1.31 Million	151,334 Added 840.09%	169,348 $0
Q1 2018 May 11, 2018	SELL	$2.92 - $3.81 $81 - $106	-28 Reduced 0.16%	18,014 $54,000
Q4 2017 Feb 09, 2018	SELL	$2.99 - $4.85 $70,623 - $114,556	-23,620 Reduced 56.69%	18,042 $55,000
Q3 2017 Nov 09, 2017	BUY	$3.01 - $5.41 $125,402 - $225,391	41,662	41,662 $195,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$897,750
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$191,520
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$79,800
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$11,910
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$4,285
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account